Conditions of MTC in patients handled with liraglutide, Yet another GLP-one receptor agonist, have already been reported from the postmarketing time period; the information in these studies are insufficient to establish or exclude a causal relationship in between MTC and GLP-1 receptor agonist use in people.There happen to be some reports of thyroi